Trinucleotide expansion diseases are known to be of two varieties -those caused by toxic activity of a mutant protein and those triggered by aberrant RNA molecules containing long repeats in untranslated regions (UTRs) [1] . Inherited neurodegenerative disorders, such as Huntington's and Kennedy's diseases, and several forms of spinocerebellar ataxia (SCA) are caused by the expansion of a CAG repeat in translated exons, leading to expression of mutant proteins containing abnormally long polyglutamine domains. Until recently, it was believed that accumulation of the mutant protein was solely responsible for the pathogenesis [2] . In a recent paper [3] , Bonini and colleagues describe that RNA toxicity is involved in polyglutamine expansion diseases, thus potentially unifying pathogenic mechanisms generated by non-coding and coding trinucleotide repeats.
The initial finding of these authors that suggested a role of RNA in pathogenesis was the identification of Muscleblind, an RNA-binding protein and a splicing factor [4] , as a modifier of the eye phenotype in a Drosophila model of Machado-Joseph disease or SCA3 [5] . The protein product of the mutant ataxin-3 gene, which has been implicated in SCA3, contains an expanded polyglutamine tract encoded by around 70 CAG repeats in its carboxy-terminal domain [6, 7] . Co-expression of Drosophila Muscleblind (the MblA isoform) or human homologue MBNL1 in the Drosophila eye markedly accelerated the depigmentation and photoreceptor degeneration that is triggered by pathogenic segments of mutant ataxin-3 [3] . Muscleblind also enhanced eye defects induced by a segment of the Huntington's disease protein but not those mediated by the tau protein, which lacks a polyglutamine domain. Co-expression of Muscleblind also accelerated the death of flies expressing the pathogenic SCA3 protein in all neurons. Conversely, the lifespan of these flies was significantly prolonged in a genetic background heterozygous for a null muscleblind allele.
In contrast to the previous results, an altered form of MBNL1 that cannot bind well to RNA did not significantly enhance the eye phenotype triggered by mutant ataxin-3 [3] . The Muscleblind protein is known to bind to CUG or CCUG repeat RNAs, which are the toxic agents of myotonic dystrophy type 1 and 2, respectively. The pathogenic mechanism in these diseases involves the sequestration of Muscleblind and other splicing factors by the mutant RNA in nuclear foci, thus disturbing the normal patterns of splicing in various cell types [4, 8, 9] . Formation of double-stranded hairpin structures is required for the association of the CUG repeat RNA with Muscleblind. But MBNL1 was also shown to bind CAG repeat RNA, which forms a similar stable double-stranded structure, both in vitro and in cultured cells [10, 11] (Figure 1 ). Interestingly, in living flies, overexpression of Muscleblind increased the level of CAG repeat RNA as well as polyglutamine peptides [3] , suggesting that this protein increases deleterious phenotypes by stabilizing the pathogenic agent, whether it be RNA or protein.
To determine the exact nature of the toxic agent in their model, Bonini and colleagues [3] engineered a mutant ataxin-3 segment in which the continuous CAG repeat was replaced by an interrupted CAACAG repeat. Both repeats were expected to be translated into the same polyglutamine tract. In spite of similar levels of expressed protein, the eye phenotypes observed with each construct were strikingly different, being much alleviated with the interrupted repeat. Similarly, the lifespan of flies expressing the mutant ataxin-3 in all neurons at the same level was prolonged, but not completely rescued, when the CAG repeat was replaced by the CAACAG repeat. Interestingly, protein inclusions were found at similar abundance in both types of transgenic flies, indicating that intensity of the deleterious phenotypes does not correlate with the number of inclusions. The interrupted CAACAG repeat RNA is not expected to form stable double-stranded hairpin structures. Accordingly, co-expression of Muscleblind only slightly enhanced the eye phenotype observed with the interrupted construct and did not increase the level of this particular RNA.
Therefore, part of the toxicity in SCA3 could be due to the CAG repeat RNA. To determine whether RNA can be toxic in the absence of mutant protein, the authors expressed untranslated expanded CAG repeats inserted in the 3 0 -UTR of the DsRed gene, an ectopic fluorescent marker. Targeted expression of untranslated CAG repeat RNA in neurons induced progressive locomotor deficits, a reduction in lifespan and brain degeneration in adult flies. Expression in the eye did not modify the external morphology of this organ but resulted in degeneration of the internal retina. Therefore, untranslated CAG repeat RNA appears primarily detrimental to neurons in this model. This may in part explain the discrepancy with previously published work that ruled out a toxic role of CAG repeat RNA based on the analysis of the external appearance of the Drosophila eye [12] . The CAG repeat RNA accumulated in nuclear foci, which were smaller but comparable to foci formed by CUG repeat RNA in flies or in myotonic dystrophy patients. Expression of Muscleblind enhanced both the stability and neuronal toxicity of the CAG repeat RNA. As expected, interrupted CAACAG RNAs of similar lengths proved not to be toxic in these conditions. Again this may solve the apparent contradiction with another recently published paper that argued against direct toxicity of repeat RNA [13] . In this work, the RNA molecules expressed were large concatemers of triplets interrupted every 20 repeats, a structure that may well interfere with toxicity.
Evidence that trinucleotide repeat RNA can induce neurodegeneration was previously demonstrated in a Drosophila model of fragile X-associated tremor/ataxia syndrome (FXTAS) [14] . This disease is caused by the expansion of between 55 and 200 CGGs in the 5 0 -UTR of the FMR1 gene, leading to neuronal degeneration in the cerebellum, brain atrophy and parkinsonism. Expression of an untranslated CGG RNA of 90 repeats disrupted eye morphology and induced lethality when targeted to all neurons. Here again the effect of untranslated RNA appeared to be neuron specific, as with the CAG repeat RNA. Two findings were quite unexpected in this model. First, untranslated CGG repeat RNA promoted the appearance of nuclear inclusions containing ubiquitin and Hsp70, and therefore quite similar to the inclusions formed in the presence of pathogenic polyglutamine peptides [1, 2] . Second, the RNA-mediated neurodegeneration could be suppressed by overexpression of the chaperone protein Hsp70, as is the case in polyglutamine disease models [15] . This suggested that the toxic RNA could trigger protein misfolding and aggregation. Although this is not reported in the present paper by Bonini and colleagues [3] , it would be very interesting to look for the presence of nuclear inclusions and protection by Hsp70 when untranslated CAG repeat RNAs are expressed in Drosophila.
Thus, these data seem to bridge the gap between disorders mediated by polyglutamine peptides and trinucleotide repeat RNA (Figure 1 ). In one neurodegenerative disease, SCA8, the two toxic agents have been strikingly reported to be co-expressed by bidirectional transcription of a single expansion mutation, yielding on one side an untranslated CUG repeat transcript and on the other side a short protein containing almost pure polyglutamine [16] . In light of the recent results of Bonini and colleagues [3] , one could now add the CAG repeat transcript as a potential third toxic agent in this disease. The development of a Drosophila model of SCA8, based on the expression of untranslated pathogenic CUG repeat RNA, also led to the identification of Muscleblind as a modifier of eye degeneration [17] . Heterozygous loss-of-function mutations of muscleblind enhanced the eye phenotype induced by the CUG repeat RNA. In the SCA3 model, both overexpression and heterozygous mutations of muscleblind increased photoreceptor cell loss, whereas these same mutations rescued neuronal dysfunction [3] . This indicates that according to the cell context, the RNA-binding protein can enhance or decrease deleterious effects of the pathogenic RNAs and proteins. Therefore, Muscleblind is likely to play a central and complex role in various trinucleotide repeat neurodegenerative diseases.
In conclusion, this recent work brilliantly illustrates the usefulness of model organisms, and particularly the Drosophila models introduced 10 years ago, to unravel the molecular mechanisms of neurodegenerative diseases. From these efforts, it now appears that neurodegenerative diseases caused by trinucleotide expansion may share similar basic mechanisms of pathogenesis involving combined toxic effects of expanded repeat RNA and protein. Figure 1 . Both mutant RNA and protein contribute to neurodegeneration in polyglutamine expansion diseases. Polyglutamine diseases originate from an abnormally expanded CAG repeat in genomic DNA of specific genes. The encoded mRNA and proteins include an expanded CAG repeat segment and a polyglutamine domain, respectively. Proteins with a long polyglutamine domain or pure polyglutamine peptides are known to be toxic. The recent study suggests that untranslated CAG repeat RNA is also pathogenic to neurons [3] . In SCA8 and possibly other related diseases, bidirectional transcription of the mutant locus yields an untranslated and toxic CUG repeat [16] . Both the CAG and CUG repeats form double-stranded hairpins that associate with one or several molecules of the RNA-binding protein Muscleblind, which regulates trinucleotide repeat RNA toxicity and could play a significant role in pathogenesis of polyglutamine diseases. (Annular structures of the polyglutamine peptide and Muscleblind protein are inferred from [18] and [11] , respectively.)
Regeneration was once thought to be exclusive to young neurons. Now, a new study shows that functional and interconnected hippocampal neurons have the potential to quickly recover from losing an axon. They do so by signaling a dendrite to change its specification and replace the missing axon by rearranging the microtubule cytoskeleton.
Eric S. Sweet 1,2 and Bonnie L. Firestein 1, * Neurons are highly polarized cells, with neurotransmitters from neighboring axons binding to receptors on dendrites, thus allowing for directional signaling. Disruption of this polarization by severing the axon eliminates the ability of a neuron to function. In young, immature neurons, restoration of polarity can occur by transforming a dendrite into a new axon [1] . An important, clinically relevant, question is whether this can also occur in older, mature neurons. In a new study reported in a recent issue of Current Biology, Gomis-Rü th et al. [2] show that it is possible for neurons that have already grown to maturity and established functional connections to regenerate their axons. This ability seems to stem from the neuron's capacity to continually remodel its microtubule cytoskeleton, despite the highly ordered structure needed to maintain neuronal connections. The ability for the microtubules to be remodeled has been suggested before but has not yet been shown in mature neurons [3] .
The cytoskeletal structure of neurons differs in axons and dendrites in several ways. Axons contain the microtubule-associated protein (MAP) tau while dendrites contain MAP2. The microtubules are also oriented differently in axons and dendrites, with microtubules being mostly unidirectional in the axon and bi-directional in the dendrite. In addition, axons contain more stable microtubules than do dendrites. Young, migrating neurons go through phases in which they are multipolar and eventually settle into a unipolar state before finishing their migration [4] . This process of polarization would have to involve the distinction of the axon from the many nascent extensions resulting in orientation and stability changes in the microtubule cytoskeleton. It was previously unknown if these changes were permanent.
In this new study, Gomis-Rü th et al. [2] show that mature neurons with established connections form new axons when the original axon is cut and that microtubule stability plays an important role in this process. Significantly, the authors show that new axon formation occurs both in vitro and ex vivo [2] . The authors found that axotomy closer to the cell body results in the transformation of a dendrite into a new axon. The identity of the new axons was confirmed by a number of features, including the formation of functional synapses [2] . Distal axotomy caused regrowth of the original axon (Figure 1) .
These results raise the question of how transformation of a dendrite into an axon occurs. It was recently shown that microtubule stabilization helps specify initial neuronal polarization [5] . To understand whether microtubule stability plays a role in axonal determination in mature neurons, Gomis-Rü th et al. [2] stabilized the microtubules of neurons in culture with taxol. Surprisingly, they found that this treatment causes formation of multiple axons. The study demonstrates for the first time that microtubule stability is sufficient to cause a mature neuron to form multiple axons. The transformation and growth of dendrites into axons continues after taxol has been washed out, suggesting that the initial stabilization of microtubules may be the critical signal for axonal growth.
